Reaction mass of Amines, C10-14-branched and linear alkyl, bis[2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-) (1:1) and Amines, C10-14-branched and linear alkyl, bis[2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-) and Amines, C10-14-branched and linear alkyl, [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-)

Genetic toxicity: in vitro

Administrative data

Endpoint:

in vitro gene mutation study in bacteria

Type of information:

experimental study

Adequacy of study:

key study

Study period:

06 Sep 2016 to 16 Sep 2016

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2017

Report date:

2017

Materials and methods

Test guideline

Test guideline 1

Qualifier:

according to guideline

Guideline:

OECD Guideline 471 (Bacterial Reverse Mutation Assay)

Version / remarks:

21 Jul 1997

Test guideline 2

Qualifier:

according to guideline

Guideline:

EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)

Version / remarks:

No. L142, 30 May 2008

Test guideline 3

Qualifier:

according to guideline

Guideline:

EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)

Version / remarks:

Aug 1998

GLP compliance:

yes (incl. QA statement)

Type of assay:

bacterial reverse mutation assay

Test material

Test material information

Constituent 1

Reference substance name:

Reaction mass of Amines, C10-14-branched and linear alkyl, bis[2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-) (1:1) and Amines, C10-14-branched and linear alkyl, bis[2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-) and Amines, C10-14-branched and linear alkyl, [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-)

EC Number:

943-133-8

Molecular formula:

C32H22CrN10O8.C10-14H21-29NH2 / C34H24CrN8O6.C10-14H21-29NH2 / C33H23CrN9O7.C10-14H21-29NH2

IUPAC Name:

Reaction mass of Amines, C10-14-branched and linear alkyl, bis[2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-) (1:1) and Amines, C10-14-branched and linear alkyl, bis[2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-) and Amines, C10-14-branched and linear alkyl, [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-)

Test material form:

solid

Specific details on test material used for the study:

SOURCE OF TEST MATERIAL
- Name of test substance: Orasol Orange 251
- Test substance No: 16/0111-1
- Source and lot/batch No.of test material: batch 002-141306
- Expiration date of the lot/batch: 15 Jun 2020
- Purity: ca. 98.8%

STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature
- Stability under test conditions: stability of the test substance under storage conditions is guaranteed until 15 Jun 2020
- Solubility and stability of the test substance in the solvent/vehicle: the test substance is soluble in DMSO used as vehicle. Test substance precipitation was found from about 333 μg/plate onward with and without S9 mix.
- Stability of test substance in the vehicle: not determined analytically, because the test substance was administered immediately after preparation and is usually stable

TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: homogeneity of the test substance was ensured by mixing before preparation of the test substance solutions
- Preliminary purification step (if any): No
- Final dilution of a dissolved solid, stock liquid or gel: the test substance was dissolved in dimethyl sulfoxide (DMSO); to achieve a clear solution of the test substance in the vehicle, the test substance preparation was treated with ultrasonic waves and was shaken thoroughly

Method

Target gene:

S. typhimurium: his
E. coli: trp

Species / strain

Species / strain 1

Species / strain / cell type:

S. typhimurium TA 1535, TA 1537, TA 98 and TA 100

Species / strain 2

Species / strain / cell type:

E. coli WP2 uvr A

Metabolic activation:

with and without

Metabolic activation system:

liver S9 mix from phenobarbital i.p. and β-naphthoflavone orally induced rats

Test concentrations with justification for top dose:

First Experiment
0; 33; 100; 333; 1000; 2500 and 5000 µg/plate (with and without S9 mix)

Second experiment
0; 1000; 2000; 2500; 3000; 4000 and 5000 µg/plate (with S9 mix)

Vehicle / solvent:

- Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: Due to the insolubility of the test substance in water, DMSO was used as vehicle, which had been demonstrated to be suitable in bacterial reverse mutation tests and for which historical control data are available

Controls

Untreated negative controls:

yes

Negative solvent / vehicle controls:

yes

True negative controls:

no

Positive controls:

yes

Positive control substance:

4-nitroquinoline-N-oxide

9-aminoacridine

other: 2-aminoantracene (2-AA); N-methyl-N'-nitro-N-nitrosoguanidine (MNNG); 4-nitro-o-phenylenediamine (NOPD)

Details on test system and experimental conditions:

METHOD OF APPLICATION: in agar (plate incorporation)
- Cell density at seeding (if applicable): Fresh cultures of bacteria were grown up to late exponential or early stationary phase of growth (approximately 10^9 cells per mL)

DURATION
- Exposure duration: 48-72 h

NUMBER OF REPLICATIONS: 3 test plates per dose or per control

STRAINS TESTED
- First experiment: TA 1535, TA 100, TA 1537, TA 98 and WP2 uvrA (with and without S9 mix)
- Second experiment: TA 98 (with S9 mix)

DETERMINATION OF CYTOTOXICITY
Toxicity detected by a:
- decrease in the number of revertants (factor ≤ 0.6)
- clearing or diminution of the background lawn (= reduced his- or trp- background growth)

Evaluation criteria:

ACCEPTANCE CRITERIA
Generally, the experiment was considered valid if the following criteria were met:
- The number of revertant colonies in the negative controls was within the range of the historical negative control data for each tester strain
- The sterility controls revealed no indication of bacterial contamination
- The positive control substances both with and without S9 mix induced a distinct increase in the number of revertant colonies within the range of the historical positive control data or above
- Fresh bacterial culture containing approximately 10^9 cells per mL were used.

ASSESSMENT CRITERIA
The test substance was considered positive in this assay if the following criteria were met:
- A dose-related and reproducible increase in the number of revertant colonies, i.e. at least doubling (bacteria strains with high spontaneous mutation rate, like TA 98, TA 100 and E.coli WP2 uvrA) or tripling (bacteria strains with low spontaneous mutation rate, like TA 1535 and TA 1537) of the spontaneous mutation rate in at least one tester strain either without S9 mix or after adding a metabolizing system.

A test substance was generally considered non-mutagenic in this test if:
- The number of revertants for all tester strains were within the range of the historical negative control data under all experimental conditions in at least two experiments carried out independently of each other.

Results and discussion

Test results

Test results 1

Key result

Species / strain:

S. typhimurium, other: TA 1535, TA 100, TA 1537

Metabolic activation:

with and without

Genotoxicity:

negative

Cytotoxicity / choice of top concentrations:

cytotoxicity

Remarks:

A bacteriotoxic effect (reduced his- background growth, decrease in the number of his+ or trp+ revertants) was observed in the standard plate test depending on the strain and test conditions from about 1000 μg/plate onward

Vehicle controls validity:

valid

Untreated negative controls validity:

valid

Positive controls validity:

valid

Test results 2

Key result

Species / strain:

S. typhimurium TA 98

Metabolic activation:

without

Genotoxicity:

positive

Remarks:

Slight increase in the number of his+ revertants at a concentration of 333 μg/plate (factor 1.7)

Cytotoxicity / choice of top concentrations:

cytotoxicity

Remarks:

A bacteriotoxic effect (reduced his- background growth, decrease in the number of his+ or trp+ revertants) was observed in the standard plate test depending on the strain and test conditions from about 1000 μg/plate onward

Vehicle controls validity:

valid

Untreated negative controls validity:

valid

Positive controls validity:

valid

Test results 3

Key result

Species / strain:

S. typhimurium TA 98

Metabolic activation:

with

Genotoxicity:

positive

Remarks:

1st Exp.: Increase in his+ revertants at conc. of 2500 and 5000 μg/plate (factors 3.2 and 2.9, resp.); 2nd Exp.: Increase in his+ revertants at conc. of 1000, 2000, 2500, 3000, 4000 and 5000 μg/plate (factors 3.6, 3.8, 3.7, 2.8, 3.0 and 2.7 resp.)

Cytotoxicity / choice of top concentrations:

no cytotoxicity

Vehicle controls validity:

valid

Untreated negative controls validity:

valid

Positive controls validity:

valid

Test results 4

Key result

Species / strain:

E. coli WP2 uvr A

Metabolic activation:

with and without

Genotoxicity:

negative

Cytotoxicity / choice of top concentrations:

cytotoxicity

Remarks:

A bacteriotoxic effect (reduced his- background growth, decrease in the number of his+ or trp+ revertants) was observed in the standard plate test depending on the strain and test conditions from about 1000 μg/plate onward

Vehicle controls validity:

valid

Untreated negative controls validity:

valid

Positive controls validity:

valid

Additional information on results:

TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: Test substance precipitation was found from about 333 μg/plate onward with and without S9 mix.

Any other information on results incl. tables

Strain	Test group	Dose (µg/plate)	Mean revertants per plate	Std Dev	Factor
TA 1535	DMSO	-	9.7	2.1	-
	Test item	33	12.0	6.6	1.2
		100	11.3	6.4	1.2
		333	10.7	4.6	1.1
		1000	12.0	1.7	1.2
		2500	1.7	1.2	0.2
		5000	0.0	0.0	0.0
	MNNG	5.0	5185.0	420.1	536.4
TA 100	DMSO	-	94.0	3.0	-
	Test item	33	85.3	5.5	0.9
		100	106.3	24.5	1.1
		333	112.3	13.6	1.2
		1000	23.7	4	0.3
		2500	1.7	1.2	0
		5000	0	0	0
	MNNG	5.0	3672.3	226.3	39.1
TA 1537	DMSO	-	9	1.7	-
	Test item	33	11.3	4.6	1.3
		100	14.3	2.3	1.6
		333	14.3	0.6	1.6
		1000	18.7	2.5	2.1
		2500	9	1	1
		5000	0	0	0
	AAC	100	2104.3	217.9	233.8
TA 98	DMSO	-	18	2	-
	Test item	33	20	1.7	1.1
		100	27.3	7.1	1.5
		333	30.7	8	1.7
		1000	14	1.7	0.8
		2500	1.7	1.2	0.1
		5000	0	0	0
	NOPD	10	955.3	16.7	53.1
E. coli	DMSO	-	22.7	8.1	-
	Test item	33	30.3	6.4	1.3
		100	25.3	2.9	1.1
		333	24	5.3	1.1
		1000	26	8.2	1.1
		2500	11.7	2.5	0.5
		5000	14.7	4	0.6
	4-NQO	-	18	2	-